Skip to main content

Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections


The proportion of asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains elusive and the potential benefit of systematic screening during the SARS-CoV-2-pandemic is controversial. We investigated the proportion of asymptomatic inpatients who were identified by systematic screening for SARS-CoV-2 upon hospital admission. Our analysis revealed that systematic screening of asymptomatic inpatients detects a low total number of SARS-CoV-2 infections (0.1%), questioning the cost–benefit ratio of this intervention. Even when the population-wide prevalence was low, the proportion of asymptomatic carriers remained stable, supporting the need for universal infection prevention and control strategies to avoid onward transmission by undetected SARS-CoV-2-carriers during the pandemic.


Infections with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) display a wide range of symptoms ranging from fatal sepsis with pulmonary failure, classical symptoms of a viral respiratory tract infection, atypical symptoms, such as anosmia and ageusia and the lack of any detectable disease manifestation [1]. The proportion of asymptomatic SARS-CoV-2 infections remains elusive, with studies suggesting a range of 2–100% [2,3,4,5] depending on the studied population and the epidemiological setting. Asymptomatic carriers of SARS-CoV-2 may drive ongoing transmission of SARS-CoV-2, thus maintaining the pandemic [6, 7]. Although the secondary attack rate of asymptomatic carriers seems to be lower than that of symptomatic patients [3, 8], a relevant proportion of seemingly healthy but SARS-CoV-2 transmitting people may limit the impact of contact tracing and omission of subsequent spread significantly. Resources in terms of workforce, testing materials and personal protective equipment may be particularly restricted in the setting of a pandemic, so that they should be allocated to the most effective points of application. As the diagnostic yield of systematic screening to detect asymptomatic SARS-CoV-2-carriers on admission to an acute care facility is controversial, we investigated the proportion of asymptomatic SARS-CoV-2-infected inpatients.


All adult patients admitted from 01.04.2020 to 14.06.2020 to the University Hospital Basel, a tertiary care center in Switzerland with more than 35,000 hospital admissions annually, were routinely tested for SARS-CoV-2 within 72 h of admission. Nasopharyngeal swabs were performed by a specially trained and dedicated team throughout the study period. An internally developed reverse transcription quantitative nucleic acid assay [9] and a commercial assay (E-gene; Roche, Rotkreuz, Switzerland) were used to detect SARS-CoV-2 RNA. Each patient screened during the study period was retrospectively classified as symptomatic or asymptomatic for coronavirus disease 2019 (COVID-19) at time of testing based on medical chart review. The classification criteria were the same as for the clinical consideration of COVID-19 and consistently applied during the screening period: acute pulmonary symptoms and/or fever ≥ 38.0 °C and/or sudden onset of anosmia or ageusia, and/or acute confusion or deterioration in the elderly, unless otherwise explained. The number of positive tested patients in the Canton Basel-Stadt, the main catchment area of the University Hospital Basel, was surveyed by and retrieved from the cantonal authorities [10] with most SARS-CoV-2 tests deriving from the triage- and test center of the University Hospital Basel [11]. Categorical variables were summarized as counts and proportions and continuous variables as medians and interquartile ranges. The Fisher’s exact test was used to assess differences between proportions. Approval by the local ethics committee was obtained (EKNZ-Number Req-2020-00808). We adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines [12].


During the study period, 4466 screening samples were collected from 4099 consecutive admitted patients. 49.9% of patients were female, the median age was 63 years (interquartile range 45–77 years). 2296 (51.4%), 1591 (35.6%), and 579 (13.0%) screenings were performed in the medical, surgical, and gynecology and obstetrics wards, respectively. Forty-two samples were excluded from further analyses, as they were collected for further follow-up (40 samples) or to screen contact patients (2 samples). 4050 (90.7%) screenings were classified as collected from asymptomatic patients at the time of testing. A total of 26 screenings (0.6%) tested positive for SARS-CoV-2: six of which were taken from asymptomatic patients (23.1% of all positive and 0.1% of all asymptomatic patients respectively) (Fig. 1). One out of six asymptomatic SARS-CoV-2-positive patients became symptomatic over the course of the hospitalization. However, symptoms could also be explained by the concomitant diagnosis of pyelonephritis. During the study period, the Canton Basel-Stadt reported 676 SARS-CoV-2-infections 44with an average population of 201′504 people (prevalence 0.3%) [10, 13]. The proportion of asymptomatic patients among all SARS-CoV-2-infected inpatients remained constant throughout the study period (21% (4/19) in April, 33% (2/6) in May, 0% (0/0) in June, p = 0.634), while the population-wide prevalence decreased.

Fig. 1
figure 1

Results of SARS-CoV-2 screening samples from asymptomatic and symptomatic patients (overall and stratified by ward types)


Systematic screening of asymptomatic inpatients revealed a low total number of SARS-CoV-2 infections, yet a stable proportion of asymptomatic carriers over time.

This result is in line with other findings. Lavezzo et al. investigated the effects of lockdown and social distancing in the Italian town of Vo. They routinely tested over 70% of the community with nasopharyngeal swabs at the beginning of the lockdown in February 2020 and again, 2 weeks later, in March 2020. The prevalence of SARS-CoV-2 decreased from 2.6 to 1.2%. Symptoms in positive tested participants were systematically recorded. Notably, approximately 40% of people who tested positive were asymptomatic at both survey time-points [14]. The overall proportion of 23.1% of positive screenings in asymptomatic patients, identified in our study, was in the middle to lower range of reported asymptomatic infections in other studies: under 50% after direct contact with patients [3, 15] and in nursing home staff [16, 17], up to 75% in general population testing [14], up to 100% in health care workers [4], and 45% [18]–100% [5] in obstetric patients. In our sample, median age was 63 years. Higher age may correlate with the development of typical clinical symptoms of COVID-19 [19]. A recent meta-analysis found that in obstetric patients, 95% (45–100%) of SARS-CoV-2 infections were asymptomatic, whereas asymptomatic SARS-CoV-2 infection among nursing home residents occurred in 54% (42–65%) of patients [20] supporting a higher proportion of asymptomatic courses among younger age groups. High proportions of asymptomatic infections in both young and elderly people were found in an analysis of SARS-CoV-2 outbreaks in six care homes in Great Britain. The researchers swabbed every resident as well as the staff and followed them up for 14 days to classify individuals as being symptomatic, presymptomatic, postsymptomatic or asymptomatic throughout the study period. Among the elderly residents, nearly 40% tested positive, among the younger staff approximately 21%. In both groups, the proportion of asymptomatic individuals, was almost 64% at the time of testing. Over the course of the study, symptoms developed in 31.3% of asymptomatic residents and in 13.3% of the asymptomatic staff [21]. Extremely low asymptomatic carriage was predominantly reported early on in the pandemic [2, 22], which might have been due to testing being predominantly performed in symptomatic individuals.

Our study has some important limitations including the retrospective categorization of symptoms related to COVID-19 and its reliance on medical chart review. However, patients undergo a standardized evaluation during admission, improving the quality of such data. Furthermore, results are only generalizable to inpatients admitted to an acute care facility during a low endemicity setting or to younger patient populations, especially children. A higher total number of asymptomatic carriers of SARS-CoV-2 may have been identified, when screening in a higher endemicity setting and including younger patient populations.


The high number needed to screen, to identify asymptomatic SARS-CoV-2 infected patients, questions the benefits of systematic on admission screening. The substantial proportion of asymptomatic SARS-CoV-2 infections, even in a low prevalence setting, emphasizes the need for universal infection and transmission control measures in health care institutions to prevent onward transmission by undetected SARS-CoV-2-carriers.

Availability of data and materials

The dataset generated and analyzed during the current study is available in the figshare repository, The relevant data of public datasets analyzed during the current study are available in the figshare repository, and [10, 13].



Severe acute respiratory syndrome coronavirus 2


Ribonucleic acid


Coronavirus disease 2019


Ethikkommission der Nordwest- und Zentralschweiz (Ethics Committee of Northwestern and Central Switzerland)


Strengthening the Reporting of Observational Studies in Epidemiology Guidelines


  1. Borges do Nascimento IJ, von Groote TC, O’Mathúna DP, et al. Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: a systematic review and series of meta-analyses. PLoS ONE. 2020;15(9):e0239235.

    Article  CAS  Google Scholar 

  2. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42.

    Article  CAS  Google Scholar 

  3. Zhang X, Chen L, Wei J, et al. Asymptomatic subclinical cases of coronavirus disease 2019 without viral transmission in three independent families. Infect Drug Resist. 2020;13:3267–71.

    Article  CAS  Google Scholar 

  4. Lai X, Wang M, Qin C, et al. Coronavirus Disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China. JAMA Netw Open. 2020;3(5):e209666.

    Article  Google Scholar 

  5. Ochiai D, Kasuga Y, Iida M, et al. Universal screening for SARS-CoV-2 in asymptomatic obstetric patients in Tokyo, Japan. Int J Gynaecol Obstet. 2020;150(2):268–9.

    Article  CAS  Google Scholar 

  6. Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406–7.

    Article  CAS  Google Scholar 

  7. Gandhi M, Yokoe DS, Havlir DV. Asymptomatic transmission, the Achilles’ Heel of current strategies to control Covid-19. N Engl J Med. 2020;382(22):2158–60.

    Article  CAS  Google Scholar 

  8. Koh WC, Naing L, Chaw L, et al. What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors. PLoS ONE. 2020;15(10):e0240205.

    Article  CAS  Google Scholar 

  9. Leuzinger K, Roloff T, Gosert R, et al. epidemiology of severe acute respiratory syndrome Coronavirus 2 emergence amidst community-acquired respiratory viruses. J Infect Dis. 2020;222(8):1270–9.

    Article  CAS  Google Scholar 

  10. Präsidialdepartement. Coronavirus (COVID-19): Fallzahlen: Fachstelle für OGD Basel-Stadt; 2020.

  11. Mansella G, Rueegg M, Widmer AF, et al. COVID-19 triage and test center: safety, feasibility, and outcomes of low-threshold testing. J Clin Med. 2020;9(10):3217.

    Article  CAS  Google Scholar 

  12. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.

    Article  Google Scholar 

  13. Statistisches. Amt Basel Stadt. Einwohnerzahl: Canton Basel Stadt; 2020

  14. Lavezzo E, Franchin E, Ciavarella C, et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’. Nature. 2020;584(7821):425–9.

    Article  CAS  Google Scholar 

  15. Park SY, Kim YM, Yi S, et al. Coronavirus disease outbreak in call center, South Korea. Emerg Infect Dis. 2020;26(8):1666–70.

    Article  CAS  Google Scholar 

  16. Roxby AC, Greninger AL, Hatfield KM, et al. Detection of SARS-CoV-2 among residents and staff members of an independent and assisted living community for older adults—Seattle, Washington, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):416–8.

    Article  CAS  Google Scholar 

  17. Dora AV, Winnett A, Jatt LP, et al. Universal and serial laboratory testing for SARS-CoV-2 at a long-term care skilled nursing facility for Veterans—Los Angeles, California, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(21):651–5.

    Article  CAS  Google Scholar 

  18. Goldfarb IT, Diouf K, Barth WH, et al. Universal SARS-CoV-2 testing on admission to the labor and delivery unit: low prevalence among asymptomatic obstetric patients. Infect Control Hosp Epidemiol. 2020;41(9):1095–6.

    Article  Google Scholar 

  19. Kronbichler A, Kresse D, Yoon S, et al. Asymptomatic patients as a source of COVID-19 infections: a systematic review and meta-analysis. Int J Infect Dis. 2020;98:180–6.

    Article  CAS  Google Scholar 

  20. Yanes-Lane M, Winters N, Fregonese F, et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: a systematic review and meta-analysis. PLoS ONE. 2020;15(11):e0241536.

    Article  CAS  Google Scholar 

  21. Ladhani SN, Chow JY, Janarthanan R, et al. Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020. EClinicalMedicine. 2020;26:100533.

    Article  Google Scholar 

  22. Wei WE, Li Z, Chiew CJ, et al. Presymptomatic transmission of SARS-CoV-2 - Singapore, January 23–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):411–5.

    Article  CAS  Google Scholar 

Download references


Not applicable.


The University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology, provided financial support for this investigator-driven study and covered the costs for the human resources to conduct the study. The University Hospital Basel had no influence on the design of the study and collection, analysis, and interpretation of data and on the writing of the manuscript.

Author information

Authors and Affiliations



RNS was involved in the acquisition of patient data, analysis and interpretation of the study data, drafting and revision of the manuscript. LM and RS collected the SARS-Cov-2 screening data and patient data and were involved in their interpretation and revised the manuscript. LA, AFW, HP, RS, LS and MB interpreted the study data and revised the manuscript. FF was involved with the acquisition and interpretation of SARS-Cov-2 screening data and revised the manuscript. CR helped conceiving the study, was involved in the interpretation of the study data and revised the manuscript. RK coordinated the specially trained and dedicated team performing the nasopharyngeal swabs, was involved in the interpretation of the study data and revised the manuscript. RB coordinated the screening process in the emergency department, was involved in the interpretation of the study data and revised the manuscript. KMR supervised the microbiological analysis, was involved in the interpretation of the study data and revised the manuscript. CM and WK supported the conception of the study, interpreted the study data and revised the manuscript. HHH and AE supervised analysis of patient screening materials, provided data for SARS-CoV-2-testing, were involved in the interpretation of the study data and revised the manuscript. SB supported the coordination of screening on the medical wards, was involved in the interpretation of the study data and revised the manuscript. STS conceived the study, analyzed and interpreted the study data, drafted and revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Sarah Tschudin-Sutter.

Ethics declarations

Ethics approval and consent to participate

Need for approval for this study was waived by the Ethics Committee of Northwestern and Central Switzerland (Ethikkommission Nordwest- und Zentralschweiz) (EKNZ-number: Req-2020-00808). They confirmed that the study follows the principles of the Law on human research (Humanforschungsgesetz Art. 51 Abs. 2).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stadler, R.N., Maurer, L., Aguilar-Bultet, L. et al. Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections. Antimicrob Resist Infect Control 10, 44 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: